Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 2 | 0 | €127.95 | €140.60 | 9.889% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €9.91 | €22.78 | 129.775% |
| Halozyme Therapeutics Inc. | 14 | 0 | 1 | 0 | €40.35 | €50.33 | 24.740% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.60 | €248.57 | 16.919% |
| Alnylam Pharmace. | 36 | 0 | 1 | 0 | €137.40 | €236.30 | 71.978% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €151.35 | €184.76 | 22.075% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €4.79 | €4.62 | -3.551% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.65 | €3.70 | 124.242% |
| PTC Therapeutics Inc. | 13 | 5 | 0 | 0 | €29.20 | €41.81 | 43.199% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €31.00 | €38.99 | 25.770% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €363.40 | €421.61 | 16.017% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | €38.00 | €84.74 | 123.011% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €18.79 | - | - |
| United Therapeutics | 18 | 0 | 0 | 0 | €249.20 | €288.66 | 15.835% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €97.50 | - | - |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €19.46 | €26.01 | 33.640% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.71 | €55.00 | 6.362% |